BSE filing, NSE: JSIPL. Summary written from the filing by ALFA Finder's alert engine.
Jindal Supreme (India) Ltd: key numbers
- Share price
- ₹148.63
- Market cap
- ₹758.4 Cr
- Revenue (annual)
- ₹675.4 Cr
- Net profit (annual)
- ₹22.53 Cr
- Promoter holding
- 73.68%
- FII holding
- 6.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jindal Supreme (India) Ltd
All →Jindal Supreme (India) Management Change
Jindal Supreme (India) appointed Somnath Arora as Plant Head (Senior Management) at its Hisar plant, effective October 8, 2026. The Board approved the role on NRC recommendation.
Jindal Supreme (India) Management Change
Mr. Narendra Singh has resigned from his position as Plant Head (Senior Management Personnel) at Jindal Supreme (India) Limited. The resignation is effective from September 28, 2026.
Jindal Supreme (India) Other Announcement
Jindal Supreme (India) Ltd submitted its quarterly shareholding pattern for the period ended September 21, 2026, outlining the distribution of stake among shareholders.
Jindal Supreme (India) Capital Structure Change
Non-promoter entity Craft Emerging Market Fund PCC acquired 2,953,204 shares of Jindal Supreme (India) Ltd via an anchor investment in the company's IPO.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.